Skip to search formSkip to main contentSkip to account menu

BRANCHIOOTIC SYNDROME 3 (disorder)

Known as: BO Syndrome 3, BOS3, BRANCHIOOTIC SYNDROME 3 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Purpose The outcome and proportion of patients with bone-only (BO) metastatic breast cancer (MBC) has not been well described. We… 
2015
2015
A new class of cyclopentadiene-bis(oxazoline) compounds and their piano-stool-type organometallic complexes have been prepared as… 
2014
2014
Resveratrol has been examined in several model systems for potential effects against cancer. Adenosine monophosphate-activated… 
2010
2010
Spectral-fluorescent properties of benzothiazole styryl monomer (Bos-3) and homodimer (DBos-21) dyes in presence of DNA were… 
2007
2007
  • E.
  • 2007
  • Corpus ID: 53341068
Present exposures of lacustrine shelves 10 to 12 miles inland from the arctic coast of Alaska occur in response to intersection… 
2006
2006
Summary: Properties of a series of hyperbranched polyfluorenes were investigated. Increasing the benzene “crosspoint” density… 
2003
2003
A novel 1-aminocyclopropane-1-carboxylate (ACC) oxidase gene (Bo-ACO3) was first isolated from senescing broccoli florets by… 
2001
2001
The preventive effect of the herbal formulation, ‘Dae‐Bo‐Won‐Chun’ (DBWC), on the progress of bone loss induced by ovariectomy…